SCHEMBL20845314

SCHEMBL20845314

C1=C\c2ccc(-c3nc(-c4cccc(-c5cccnc5)c4)nc(-c4cccc(-c5cccnc5)c4)n3)cc2-c2ccccc2Sc2ccccc2-c2ccccc2/1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 5/20 0.41
▸ CYP11B2 P19099 5/20 0.41
▸ CYP19A1 P11511 3/20 0.41
▸ CYP17A1 P05093 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RAB9A P51151 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ PGR P06401 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ PSIP1 O75475 1/20 0.36
▸ AXL P30530 1/20 0.36
▸ MKNK1 Q9BUB5 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36
▸ KMO O15229 1/20 0.36
▸ DRD2 P14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845324 0.93 ALDH1A1 (0.41) CYP11B1CYP11B2CYP19A1CYP17A1ALDH1A1
SCHEMBL20845330 0.89 CYP19A1 (0.42) CYP11B1CYP11B2CYP19A1CYP17A1ALDH1A1
SCHEMBL20845334 0.88 RAB9A (0.39) CYP11B1CYP11B2CYP19A1CYP17A1ALDH1A1
SCHEMBL20845319 0.88 GP6 (0.33) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL20845246 0.88 CYP19A1 (0.43) CYP11B1CYP11B2CYP19A1CYP17A1ALDH1A1
SCHEMBL20845323 0.87 MEN1 (0.34) ALDH1A1MAPTTSHRRAB9ASMN1; SMN2
SCHEMBL20845002 0.86 CYP19A1 (0.41) CYP11B1CYP11B2CYP19A1CYP17A1ALDH1A1
SCHEMBL20845007 0.85 CYP19A1 (0.43) CYP11B1CYP11B2CYP19A1CYP17A1ALDH1A1
SCHEMBL20845327 0.85 ALDH1A1 (0.43) CYP11B1CYP11B2CYP19A1CYP17A1ALDH1A1
SCHEMBL20845141 0.84 MEN1 (0.37) ALDH1A1MAPTPOLBTSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SCO2, AOX1, ORC3 CYP11B1 609/4885CYP11B2 504/4885CYP19A1 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback